Assessment begins witha defined question.

Real Intelligence Review considers confidential inquiries from developers and institutions seeking independent assessment of an AI-enabled health product.

Private correspondence

RIR considers products that could materially influence a health decision.

An initial inquiry should make the intended use and consequence of the product clear. It should also identify the available evidence and the access needed for meaningful review.

A current product version can be identified and made available for review.

The intended use, users, population, and care setting can be defined.

The available studies, datasets, regulatory information, and limitations can be shared.

The applicant accepts that payment does not guarantee a favorable finding or publication.

A clear path from inquiry to finding.

Scope, access, deliverables, timing, and fees are documented before assessment work begins.

01

Define the question

Document the product, version, intended use, users, population, setting, claims, and reason for assessment.

02

Set the scope

Determine whether the inquiry is suitable and what evidence, access, testing, and review would be required.

03

Conduct the assessment

Review evidence, apply the agreed methods, document limitations, and report the resulting findings.

Request consideration for independent assessment.

Please identify the product, intended use, users, population, current version, available evidence, and why independent assessment would be consequential.

Private correspondence

Assessment inquiry

Do not include patient-identifiable information or other sensitive health information in an initial inquiry.

Send an assessment inquiry

An inquiry does not create an assessment relationship or guarantee acceptance, publication, or any particular finding.